# EDGAR Filing Document

**Accession Number:** 0001621221
**File Stem:** 0001640334-26-000506
**Filing Date:** 2026-3
**Character Count:** 2313
**Document Hash:** 2d3845a70da6919eb292e9e147f7932d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001640334-26-000506.hdr.sgml**: 20260519

**ACCESSION NUMBER**: 0001640334-26-000506

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260320

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ARTELO BIOSCIENCES, INC.
- **CENTRAL INDEX KEY:** 0001621221
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 331220924
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 505 LOMAS SANTA FE, SUITE 160
- **CITY:** SOLANA BEACH
- **STATE:** CA
- **ZIP:** 92075
- **BUSINESS PHONE:** 858-925-7049

**MAIL ADDRESS:**
- **STREET 1:** 505 LOMAS SANTA FE, SUITE 160
- **CITY:** SOLANA BEACH
- **STATE:** CA
- **ZIP:** 92075

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** REACTIVE MEDICAL INC.
- **DATE OF NAME CHANGE:** 20170207

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** KNIGHT KNOX DEVELOPMENT CORP.
- **DATE OF NAME CHANGE:** 20141001

**Artelo Biosciences, Inc.**

505 Lomas Santa Fe, Suite 160

Solana Beach, CA 92075

March 20, 2026

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, DC. 20549

Attn: Doris Stacey Gama

---

| | |
|:---|:---|
| **Re:**  | **Artelo Biosciences, Inc.** |
|  | **Registration Statement on Form S-1 (File No. 333-294506)** |

---

Ladies and Gentlemen,

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Artelo Biosciences, Inc. hereby respectfully requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1 (the "Registration Statement") and declare such Registration Statement effective at 5:00 p.m. (Eastern Time) on Tuesday, March 24, 2026, or as soon thereafter as practicable.

It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Louis A. Bevilacqua of Bevilacqua PLLC at (202) 869-0888, ext. 100.

---

| | |
|:---|:---|
| Respectfully, | Respectfully, |
| Artelo Biosciences, Inc. | Artelo Biosciences, Inc. |
| By: | /s/ Gregory D. Gorgas |
|  | Gregory D. Gorgas |
|  | Chief Executive Officer |

---

cc: Louis A. Bevilacqua, Esq.